FSSAI suspends Dior Pharmaceuticals’ nutraceutical manufacturing licence
India’s food regulator has suspended Dior Pharmaceuticals’ Punjab manufacturing licence with immediate effect after identifying critical GMP, hygiene, sanitation, storage and traceability gaps. Operations must remain halted until deficiencies are rectified and compliance is demonstrated.
FSSAI suspended Dior Pharmaceuticals' Punjab nutraceutical manufacturing licence with immediate effect after finding critical GMP, hygiene, safety-management, sanitation, storage and traceability violations. The company must cease operations until deficiencies are rectified and compliance is demonstrated.
Why this matters
The suspension follows recent signals that FSSAI suspended Dior Pharmaceuticals’ food licence over Punjab plant violations and its nutraceutical manufacturing licence, pointing to continuing regulatory concerns at the facility.
Retail-company signals are accelerating, up 314100% QoQ.